Publicacións en colaboración con investigadores/as de Universidad Camilo José Cela (54)

2020

  1. Effect of an abdominal hypopressive technique programme on pelvic floor muscle tone and urinary incontinence in women: a randomised crossover trial

    Physiotherapy (United Kingdom), Vol. 108, pp. 37-44

2018

  1. The revised Bristol Rheumatoid Arthritis Fatigue measures and the Rheumatoid Arthritis Impact of Disease scale: Validation in six countries

    Rheumatology (United Kingdom), Vol. 57, Núm. 2, pp. 300-308

2017

  1. EULAR/PReS standards and recommendations for the transitional care of young people with juvenile-onset rheumatic diseases

    Annals of the Rheumatic Diseases, Vol. 76, Núm. 4, pp. 639-646

  2. Transitional care for rheumatic conditions in Europe: Current clinical practice and available resources

    Pediatric Rheumatology, Vol. 15, Núm. 1

2016

  1. Systematic review and critical appraisal of transitional care programmes in rheumatology

    Seminars in Arthritis and Rheumatism, Vol. 46, Núm. 3, pp. 372-379

  2. Translating patient reported outcome measures: Methodological issues explored using cognitive interviewing with three rheumatoid arthritis measures in six European languages

    Rheumatology (United Kingdom), Vol. 55, Núm. 6, pp. 1009-1016

2015

  1. Adherence to biologic therapies and associated factors in rheumatoid arthritis, spondyloarthritis and psoriatic arthritis: A systematic literature review

    Clinical and Experimental Rheumatology, Vol. 33, Núm. 4, pp. 559-569

  2. High sodium intake is associated with self-reported rheumatoid arthritis: A cross sectional and case control analysis within the SUN cohort

    Medicine (United States), Vol. 94, Núm. 37

  3. Incidence of physical disability related to musculoskeletal disorders in the elderly: Results from a primary care-based registry

    Arthritis Care and Research, Vol. 67, Núm. 1, pp. 89-93

2014

  1. Bone mineral density status and frequency of osteoporosis and clinical fractures in 155 patients with psoriatic arthritis followed in a university hospital

    Reumatologia Clinica, Vol. 10, Núm. 2, pp. 89-93

  2. Diagnostic value of clinical, laboratory, and imaging findings in patients with a clinical suspicion of gout: A systematic literature review

    Journal of Rheumatology, Vol. 41, Núm. SUPPL. 92, pp. 3-8

  3. Facteur rhumatoïde et réponse aux anti-TNF dans la polyarthrite rhumatoïde: revue systématique et méta-analyse d'études observationnelles

    Revue du Rhumatisme (Edition Francaise), Vol. 81, Núm. 1, pp. 58-68

  4. Multinational evidence-based recommendations for the diagnosis and management of gout: Integrating systematic literature review and expert opinion of a broad panel of rheumatologists in the 3e initiative

    Annals of the Rheumatic Diseases, Vol. 73, Núm. 2, pp. 328-335

  5. Observational study of optimization of biologic therapies in rheumatoid arthritis: A single-centre experience

    Rheumatology International, Vol. 34, Núm. 8, pp. 1059-1063

  6. Performance of the Assessment of Spondyloarthritis International Society criteria for the classification of spondyloarthritis in early spondyloarthritis clinics participating in the ESPERANZA programme

    Rheumatology (United Kingdom), Vol. 53, Núm. 2, pp. 353-360

  7. Rheumatoid factor and response to TNF antagonists in rheumatoid arthritis: Systematic review and meta-analysis of observational studies

    Joint Bone Spine, Vol. 81, Núm. 1, pp. 41-50

  8. Safety profile of protein kinase inhibitors in rheumatoid arthritis: Systematic review and meta-analysis

    Annals of the Rheumatic Diseases, Vol. 73, Núm. 5, pp. 871-882

  9. Serious infections in patients with rheumatoid arthritis and other immune-mediated connective tissue diseases exposed to anti-TNF or rituximab: Data from the Spanish registry BIOBADASER 2.0

    Rheumatology International, Vol. 34, Núm. 7, pp. 953-961

  10. The efficacy and safety of treatments for acute gout: Results from a series of systematic literature reviews including cochrane reviews on intraarticular glucocorticoids, colchicine, nonsteroidal antiinflammatory drugs, and interleukin-1 inhibitors

    Journal of Rheumatology, Vol. 41, Núm. SUPPL. 92, pp. 15-25

  11. Tophaceous gout and high level of hyperuricaemia are both associated with increased risk of mortality in patients with gout

    Annals of the Rheumatic Diseases, Vol. 73, Núm. 1, pp. 177-182